S100A8/A9 and S100A9 reduce acute lung injury

Immunology and Cell Biology

Volumn 95, Issue 5, 2017, Pages 461-472

  Hiroshima, Yuka ^a,b   Hsu, Kenneth ^a   Tedla, Nicodemus ^a   Wong, Sze Wing ^a   Chow, Sharron ^a   Kawaguchi, Naomi ^a,c   Geczy, Carolyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN S 100; SERUM AMYLOID A; SERUM AMYLOID A3; SIRTUIN 1; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; AUTACOID;

ACUTE LUNG INJURY; AIRWAY EPITHELIUM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INHALATION; LUNG PARENCHYMA; LYMPHOCYTE; MAST CELL DEGRANULATION; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN HOMEOSTASIS; SIGNAL TRANSDUCTION; TRACHEA EPITHELIUM; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; LUNG; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHOSPHORYLATION;

ACUTE LUNG INJURY; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CXCL10; FEMALE; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTES; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; PHOSPHORYLATION; S100 PROTEINS; SIGNAL TRANSDUCTION;

EID: 85011311765     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2017.2     Document Type: Article

References (47)

1. Gomes LH, Raftery MJ, Yan WX, Goyette JD, Thomas PS, Geczy CL. S100A8 and S100A9-oxidant scavengers in inflammation. Free Radic Biol Med 2013; 58: 170-186.
2. Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007; 81: 28-37.
3. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem 2009; 8: 290-305.
4. Geczy CL, Chung YM, Hiroshima Y. Calgranulins may contribute vascular protection in atherogenesis. Circ J 2014; 78: 271-280.
5. Hobbs JA, May R, Tanousis K, McNeill E, Mathies M, Gebhardt C et al. Myeloid cell function in MRP-14 (S100A9) null mice. Mol Cell Biol 2003; 23: 2564-2576.
6. Passey RJ, Williams E, Lichanska AM, Wells C, Hu S, Geczy CL et al. A null mutation in the inflammation-associated S100 protein S100A8 causes early resorption of the mouse embryo. J Immunol 1999; 163: 2209-2216.
7. Manitz MP, Horst B, Seeliger S, Strey A, Skryabin BV, Gunzer M et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol 2003; 23: 1034-1043.
8. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxininduced shock. Nat Med 2007; 13: 1042-1049.
9. Boyd JH, Kan B, Roberts H, Wang Y, Walley KR. S100A8 and S100A9 mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products. Circ Res 2008; 102: 1239-1246.
10. Zhao J, Endoh I, Hsu K, Tedla N, Endoh Y, Geczy CL. S100A8 modulates mast cell function and suppresses eosinophil migration in acute asthma. Antioxid Redox Signal 2011; 14: 1589-1600.
11. Hiroshima Y, Hsu K, Tedla N, Chung YM, Chow S, Herbert C et al. S100A8 induces IL-10 and protects against acute lung injury. J Immunol 2014; 192: 2800-2811.
12. Harrison CA, Raftery MJ, Walsh J, Alewood P, Iismaa SE, Thliveris S et al. Oxidation regulates the inflammatory properties of the murine S100 protein S100A8. J Biol Chem 1999; 274: 8561-8569.
13. Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 2011; 41: 821-842.
14. Pagano RL, Moraes NF, De Lorenzo BH, Coccuzzo Sampaio S, Mariano M, Giorgi R. Inhibition of macrophage functions by the C-terminus of murine S100A9 is dependent on B-1 cells. Mediat Inflamm 2014; 2014: 836491.
15. Muramatsu T. Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners. J Biochem 2016; 159: 481-490.
16. Arnold V, Cummings JS, Moreno-Nieves UY, Didier C, Gilbert A, Barré-Sinoussi F et al. S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells. Retrovirology 2013; 10: 122.
17. Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205: 2235-2249.
18. Tsai SY, Segovia JA, Chang TH, Morris IR, Berton MT, Tessier PA et al. DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway. PLoS Pathog 2014; 10: e1003848.
19. Chen B, Miller AL, Rebelatto M, Brewah Y, Rowe DC, Clarke L et al. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo. PLoS ONE 2015; 10: e0115828.
20. Achouiti A, Vogl T, Van der Meer AJ, Stroo I, Florquin S, de Boer OJ et al. Myeloidrelated protein-14 deficiency promotes inflammation in staphylococcal pneumonia. Eur Respir J 2015; 46: 464-473.
21. De Filippo K, Neill DR, Mathies M, Bangert M, McNeill E, Kadioglu A et al. A new protective role for S100A9 in regulation of neutrophil recruitment during invasive pneumococcal pneumonia. FASEB J 2014; 28: 3600-3608.
22. Fontaine M, Pachot A, Larue A, Mougin B, Landelle C, Venet F et al. Delayed increase of S100A9 messenger RNA predicts hospital-acquired infection after septic shock. Crit Care Med 2011; 39: 2684-2690.
23. Anthony D, Seow HJ, Uddin M, Thompson M, Dousha L, Vlahos R et al. Serum amyloid A promotes lung neutrophilia by increasing IL-17 A levels in the mucosa and gammadelta T cells. Am J Resp Crit Care Med 2013; 188: 179-186.
24. Hua S, Song C, Geczy CL, Freedman SB, Witting PK. A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis. Redox Rep 2009; 14: 187-196.
25. Schelbergen RF, Blom AB, van den Bosch MH, Sloetjes A, Abdollahi-Roodsaz S, Schreurs BW et al. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4. Arthritis Rheum 2012; 64: 1477-1487.
26. Galli SJ, Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 2010; 40: 1843-1851.
27. Wang JX, Kaieda S, Ameri S, Fishgal N, Dwyer D, Dellinger A et al. IL-33/ST2 axis promotes mast cell survival via BCLXL. Proc Natl Acad Sci USA 2014; 111: 10281-10286.
28. Wilson TC, Bachurski CJ, Ikegami M, Jobe AH, Kallapur SG. Pulmonary and systemic induction of SAA3 after ventilation and endotoxin in preterm lambs. Pediatr Res 2005; 58: 1204-1209.
29. Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-B and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal 2013; 25: 1939-1948.
30. Yan C, Ward PA, Wang X, Gao H. Myeloid depletion of SOCS3 enhances LPS-induced acute lung injury through CCAAT/enhancer binding protein delta pathway. FASEB J 2013; 27: 2967-2976.
31. Lang T, Mansell A. The negative regulation of Toll-like receptor and associated pathways. Immunol Cell Biol 2007; 85: 425-434.
32. Biswas SK, Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol 2009; 30: 475-487.
33. Donato R, Cannon BR, Sorci G, Riuzzi F, Hsu K, Weber DJ et al. Functions of S100 proteins. Curr Mol Med 2013; 13: 24-57.
34. Wiechert L, Nemeth J, Pusterla T, Bauer C, De Ponti A, Manthey S et al. Hepatocytespecific S100A8 and S100A9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Commun Signal 2012; 10: 40.
35. Cesaro A, Anceriz N, Plante A, Page N, Tardif MR, Tessier PA. An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLoS ONE 2012; 7: e45478.
36. Philippart F, Fitting C, Cavaillon JM. Lung microenvironment contributes to the resistance of alveolar macrophages to develop tolerance to endotoxin. Crit Care Med 2012; 40: 2987-2996.
37. Natarajan S, Kim J, Remick DG. Chronic pulmonary LPS tolerance induces selective immunosuppression while maintaining the neutrophilic response. Shock 2010; 33: 162-169.
38. Natarajan S, Kim J, Remick DG. Acute pulmonary lipopolysaccharide tolerance decreases TNF-without reducing neutrophil recruitment. Immunol 2008; 181: 8402-8408.
39. Ather JL, Ckless K, Martin R, Foley KL, Suratt BT, Boyson JE et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 2011; 187: 64-73.
40. Haddad JJ, Fahlman CS. Redox-and oxidant-mediated regulation of interleukin-10: an anti-inflammatory, antioxidant cytokine? Biochem Biophys Res Commun 2002; 297: 163-176.
41. Lee HN, Kundu JK, Cha Y, Surh YJ. Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-alpha expression. J Cell Sci 2013; 126: 4037-4047.
42. Gao R, Ma Z, Hu Y, Chen J, Shetty S, Fu J. Sirt1 restrains lung inflammasome activation in a murine model of sepsis. Am J Physiol Lung Cell Mol Physiol 2015; 308: L847-L853.
43. Ikegami M, Falcone A, Whitsett JA. STAT-3 regulates surfactant phospholipid homeostasis in normal lung and during endotoxin-mediated lung injury. J Appl Physiol (1985) 2008; 104: 1753-1760.
44. Watt KW, Brightman IL, Goetzl EJ. Isolation of two polypeptides comprising the neutrophil-immobilizing factor of human leucocytes. Immunology 1983; 48: 79-86.
45. Itou H, Yao M, Fujita I, Watanabe N, Suzuki M, Nishihira J et al. The crystal structure of human MRP14 (S100A9), a Ca2+-dependent regulator protein in inflammatory process. J Mol Biol 2002; 316: 265-276.
46. Raftery MJ, Collinson L, Geczy CL. Overexpression, oxidative refolding, and zinc binding of recombinant forms of the murine S100 protein MRP14 (S100A9). Protein Expr Purif 1999; 15: 228-235.
47. Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF et al. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1. Arch Oral Biol 2011; 56: 761-767.